We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+9.31%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$273B
AUM Growth
+$20.9B
Cap. Flow
+$2.91B
Cap. Flow %
1.06%
Top 10 Hldgs %
16.06%
Holding
3,565
New
168
Increased
2,233
Reduced
898
Closed
80

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$892M
2
MRK icon
Merck
MRK
+$858M
3
AMGN icon
Amgen
AMGN
+$857M
4
HD icon
Home Depot
HD
+$837M
5
CSCO icon
Cisco
CSCO
+$781M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$776M
2
UPS icon
United Parcel Service
UPS
+$615M
3
QCOM icon
Qualcomm
QCOM
+$587M
4
BABA icon
Alibaba
BABA
+$555M
5
ETN icon
Eaton
ETN
+$508M

Sector Composition

Rank Sector Weight
1 Technology 19.68%
2 Financials 12.96%
3 Healthcare 11.88%
4 Consumer Discretionary 11.22%
5 Industrials 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NERV icon
3301
Minerva Neurosciences
NERV
$185M
$231K ﹤0.01%
9,871
+27
+0.3% +$675
BIOR
3302
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$228K ﹤0.01%
+191
New +$263K
RYM
3303
RYTHM Inc
RYM
$39.5M
$224K ﹤0.01%
+6
New +$248K
ARQ icon
3304
Arq
ARQ
$84.6M
$224K ﹤0.01%
40,607
ALDX icon
3305
Aldeyra Therapeutics
ALDX
$92.9M
$216K ﹤0.01%
18,127
CNTG
3306
DELISTED
Centogene N.V. Common Shares
CNTG
$214K ﹤0.01%
17,635
PDLB icon
3307
Ponce Financial Group
PDLB
$488M
$213K ﹤0.01%
26,678
BSCL
3308
DELISTED
Invesco BulletShares 2021 Corporate Bond ETF
BSCL
$213K ﹤0.01%
10,033
PBIP
3309
DELISTED
Prudential Bancorp, Inc.
PBIP
$212K ﹤0.01%
14,360
-4,239
-23% -$57K
CLSK icon
3310
CleanSpark
CLSK
$3.53B
$211K ﹤0.01%
8,832
+1,448
+20% +$40.9K
NYMX
3311
DELISTED
Nymox Pharmaceutical Corp
NYMX
$211K ﹤0.01%
94,996
+10,059
+12% +$26.5K
SGA icon
3312
Saga Communications
SGA
$57M
$209K ﹤0.01%
9,547
SVRA icon
3313
Savara
SVRA
$1.12B
$209K ﹤0.01%
100,055
-8,700
-8% -$14.9K
DBTX
3314
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$208K ﹤0.01%
+18,231
New +$286K
GBL
3315
DELISTED
GAMCO Investors, Inc.
GBL
$208K ﹤0.01%
11,191
-2,351
-17% -$44.5K
RMTI icon
3316
Rockwell Medical
RMTI
$28.4M
$207K ﹤0.01%
1,618
+152
+10% +$22.5K
TOON icon
3317
Kartoon Studios
TOON
$35.2M
$207K ﹤0.01%
10,629
+2,118
+25% +$40.3K
VERX icon
3318
Vertex
VERX
$2.09B
$203K ﹤0.01%
9,192
CALC icon
3319
CalciMedica
CALC
$15.8M
$202K ﹤0.01%
2,598
-197
-7% -$59K
GRTX
3320
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$202K ﹤0.01%
22,894
+4,061
+22% +$44.6K
GCBC icon
3321
Greene County Bancorp
GCBC
$570M
$201K ﹤0.01%
16,026
CDTX
3322
DELISTED
Cidara Therapeutics
CDTX
$200K ﹤0.01%
3,753
-843
-18% -$41.6K
ULBI icon
3323
Ultralife
ULBI
$86.4M
$199K ﹤0.01%
23,999
WRAP icon
3324
Wrap Technologies
WRAP
$103M
$196K ﹤0.01%
35,085
TARA icon
3325
Protara Therapeutics
TARA
$220M
$190K ﹤0.01%
12,060

Similar funds

Charles Schwab's Q1 2021 Portfolio in Review

As of Q1 2021, Charles Schwab held 3,565 positions worth $273B, up 8.3% from $252B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Charles Schwab's Q1 2021 filing shows 168 new, 2,233 increased, 898 reduced and 80 closed positions. Its largest new stake was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M. The largest sale was ExxonMobil, an estimated $776M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q1 2021 buy was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M.
  • Charles Schwab added most to Broadcom in Q1 2021, an estimated $892M increase.
  • Charles Schwab's biggest Q1 2021 reduction was ExxonMobil, cutting an estimated $776M.
  • Charles Schwab fully exited Invesco QQQ Trust in Q1 2021, selling an estimated $396M.
  • Charles Schwab's ten largest holdings make up 16% of its $273B portfolio in Q1 2021.
  • Charles Schwab opened 168 new positions and closed 80 in Q1 2021.
  • Charles Schwab's portfolio value rose 8.3% quarter-over-quarter to $273B.

Based on Charles Schwab's 13F filing for Q1 2021, filed 17 May 2021.